Frazier Life Sciences Management, L.P. - HILLEVAX INC ownership

HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$131,560,798
-21.8%
9,781,4720.0%8.74%
-13.0%
Q2 2023$168,143,504
+4.0%
9,781,4720.0%10.04%
-14.2%
Q1 2023$161,687,732
-1.0%
9,781,472
+0.2%
11.71%
+15.3%
Q4 2022$163,257,346
-2.1%
9,758,3590.0%10.15%
-21.0%
Q3 2022$166,770,000
+64.3%
9,758,359
+5.1%
12.84%
+34.1%
Q2 2022$101,493,0009,285,6829.58%
Other shareholders
HILLEVAX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$7,517,5149.98%
Frazier Life Sciences Management, L.P. 9,781,472$131,560,7988.74%
Samsara BioCapital, LLC 799,274$10,750,2353.29%
VR Adviser, LLC 2,037,313$27,401,8602.88%
StepStone Group LP 826,567$11,117,3262.48%
ACUTA CAPITAL PARTNERS, LLC 270,319$3,635,7912.44%
Deep Track Capital, LP 2,900,000$39,005,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,004,231$53,856,9071.19%
Carlyle Group Inc. 1,838,486$24,690,8671.07%
Monashee Investment Management LLC 110,000$1,479,5000.62%
View complete list of HILLEVAX INC shareholders